Eris Therapeutics Limited - Company Profile

It is a machinery and equipment public limited company based in Ahmadabad City, Gujarat, India, established in 2021.
2021 Ahmadabad City, Gujarat, India Active
Last Updated:
Access Report
About Eris Therapeutics Limited

Eris Therapeutics Limited, a active public limited company, was established on 23 June 2021 in Ahmadabad City, Gujarat, India. Engaging in industrial machinery manufacturing within the manufacturing sector, it holds CIN: U24230GJ2021PLC123519. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.01 Cr and a paid-up capital of ₹2.58 M.

Employing 611 professional, Its leadership includes Inderjeet Singh Negi (Director), Nita Prasad Borkar (Director), Sujesh Vasudevan (Director). Past directors included Nita Prasad Borkar, Sujesh Vasudevan. It holds ₹555.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 4Th Floor, A Wing, Shilp Accord,, Opposite Time Square Ii, Thaltej,, Ahmadabad City, Gujarat, 380054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2021PLC123519

  • Registration Number

    123519

  • Incorporation Date

    23 June 2021

  • Authorized Capital

    ₹3.01 Cr

  • Paid-Up Capital

    ₹2.58 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.01 Cr
  • Paid Up Capital ₹ 2.58 M
  • Company Age 4 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 555.00 Cr
Company report

Eris Therapeutics Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Eris Therapeutics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Eris Therapeutics Limited?
Current Directors
Name Designation Appointment Date Status
Inderjeet Singh Negi Director 23 Jun 2021 Current
Nita Prasad Borkar Director 30 Jul 2024 Current
Sujesh Vasudevan Director 04 Jul 2025 Current
Kaushal Kamlesh Shah Director 23 Jun 2021 Current
Sachin Shah Director 23 Jun 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eris Therapeutics.

Eris Therapeutics Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Eris Therapeutics revenue growth over time
Eris Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eris Therapeutics?

In 2023, Eris Therapeutics had a promoter holding of 99.94% and a public holding of 0.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,550,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Citi Bank N.A. : 170.00 Cr
  • Sbicap Trustee Company Limited : 150.00 Cr
  • Axis Bank Limited : 135.00 Cr
  • Hdfc Bank Limited : 100.00 Cr
Latest Charge Details
Date Lender Amount Status
19 Feb 2025 Sbicap Trustee Company Limited ₹150.00 Cr Open
30 Nov 2024 Hdfc Bank Limited ₹100.00 Cr Open
15 Dec 2023 Axis Bank Limited ₹135.00 Cr Open
08 Aug 2022 Citi Bank N.A. ₹150.00 Cr Open
08 Aug 2022 Citi Bank N.A. ₹20.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Eris Therapeutics?

Eris Therapeutics has a workforce of 611 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eris Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eris Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Eris Therapeutics Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Progress on Sujesh Vasudevan was appointed as a Director was appointed as a Director on 04 Jul 2025 & has been associated with this company since 7 months 21 days . was documented.

  • Balance Sheet

    Eris Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    Progress on A charge with Sbicap Trustee Company Limited amounted to Rs. 150.00 Cr with Charge ID 101059789 was registered on 19 Feb 2025. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 100.00 Cr with Charge ID 101017877 was registered on 30 Nov 2024. was completed.

  • Director Appointment

    Nita Prasad Borkar was appointed as a Director was appointed as a Director on 30 Jul 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Eris Therapeutics Limited?

The CIN of Eris Therapeutics Limited is U24230GJ2021PLC123519.

Where is Eris Therapeutics Limited headquartered?

Eris Therapeutics Limited is headquartered at 4Th Floor, A Wing, Shilp Accord,, Opposite Time Square Ii, Thaltej,, Ahmadabad City, Gujarat, 380054.

When was Eris Therapeutics Limited incorporated?

Eris Therapeutics Limited was incorporated on 23 June 2021.

Who are the current directors of Eris Therapeutics Limited?

The current directors of Eris Therapeutics Limited are

What is the primary industry of Eris Therapeutics Limited?

The primary industry of Eris Therapeutics Limited is Manufacturing.

Is Eris Therapeutics Limited a listed company?

Eris Therapeutics Limited is unlisted.

What is the capital structure of Eris Therapeutics Limited?

The authorized capital of Eris Therapeutics Limited is ₹3.01 Cr, and the paid-up capital is ₹2.58 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available